Subacute stent thrombosis: Evolving issues and current concepts

Journal of the American College of Cardiology

Volumn 27, Issue 2, 1996, Pages 494-503

  Mak, Koon Hou ^a   Belli, Guido ^a   Ellis, Stephen G ^a   Moliterno, David J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; TICLOPIDINE;

CORONARY ARTERY DISEASE; HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STENT; THROMBOSIS;

EID: 0030027222     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00466-1     Document Type: Review

References (102)

1. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;316:701-6.
2. Serruys PW, Strauss BH, Beatt KJ, et al. Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med 1991;324:13-7.
3. Palmaz JC, Garcia OJ, Copp DT, et al. Balloon-expandable intra-arterial stents: effect of anticoagulation on thrombus formation [abstract]. Circulation 1987;76 Suppl IV:IV-45A.
4. Schatz RA, Baim DS, Leon M, et al. Clinical experience with the Palmaz-Schatz coronary stent: initial results of a multicenter study. Circulation 1991;83:148-61.
5. Savage MP, Fischman DL, Schatz RA, et al. Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. J Am Coll Cardiol 1994;24:1207-12.
6. Carrozza JPJ, Kuntz RE, Levine MJ, et al. Angiographic and clinical outcome of intracoronary stenting: immediate and long-term results from a large single-center experience. J Am Coll Cardiol 1992;20:328-37.
7. Nath CF, Muller DWM, Ellis SG, et al. Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome. J Am Coll Cardiol 1993;21:622-7.
8. Fajadet J, Jenny D, Guagliumi G, et al. Does the indication for coronary stenting influence clinical results? [abstract]. J Am Coll Cardiol 1992;19: 198A.
9. Kimura T, Nosaka H, Yokoi H, Iwabuchi M, Nobuyoshi M. Serial angiographic follow-up after Palmaz-Schatz stent implantation: comparison with conventional balloon angioplasty. J Am Coll Cardiol 1993;21: 1557-63.
10. Hearn JA, King SB III, Douglas JS, et al. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty: initial results with a balloon-expandable, stainless steel design. Circulation 1993;88:2086-96.
11. Sutton JM, Ellis SG, Roubin GS, et al. Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. Circulation 1994;89:1126-37.
12. Strauss BH, Serruys PW. Coronary wallstent. In: Topol EJ, ed. Textbook of Interventional Cardiology. Philadelphia: W. B. Saunders, 1994:687-701.
13. Eeckhout E, Goy J-J, Vogt P, et al. Complications and follow-up after coronary stenting: critical analysis of a 6-year single-center experience. Am Heart J 1994;127:262-72.
14. George BS, Voorhees WD III, Roubin GS, et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcome. J Am Coll Cardiol 1993;22:135-42.
15. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
16. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95.
17. Penn IM, Brown RI, Almond D, et al. Stent thrombosis remains the major early limitation in elective stenting: inhospital and six week outcome of TASC I [abstract]. Circulation 1994;90 Suppl I:I-650.
18. Roubin GS, Cannon AD, Agrawal SK, et al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992;85:916-27.
19. Colombo A, Goldberg SL, Almagor Y, Maiello L, Finci L. A novel strategy for stent deployment in the treatment of acute or threatened closure complicating balloon coronary angioplasty. Use of short or standard (or both) single or multiple Palmaz-Schatz stents. J Am Coll Cardiol 1993;22: 1887-91.
20. Vrolix M, Piessens J. Usefulness of the Wiktor stent for treatment of threatened or acute closure complicating coronary angioplasty. Am J Cardiol 1994;73:737-41.
21. Herrmann HC, Buchbinder M, Clemen MW, et al. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty. Circulation 1992;86:812-9.
22. Shaknovich A, Moses JW, Bailey S, et al. Subacute stent thrombosis in the Stent REStenosis Study (STRESS): clinical impact and predictive factors [abstract]. Circulation 1994;90 Suppl I:I-650.
23. Haude M, Erbel R, Issa H, et al. Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Am Heart J 1993;126: 15-22.
24. Schömig A. Kastrati A, Mudra H, et al. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure. Circulation 1994;90:2716-24.
25. Foley JB, Brown RIG, Penn IM. Thrombosis and restenosis after stenting in failed angioplasty: comparison with elective stenting. Am Heart J 1994;128:12-20.
26. Whitlow PL, de Jaegere PP, Serruys PW. The Wiktor stent. In: Topol EJ, editor. Textbook of Interventional Cardiology. Philadelphia: Saunders, 1994:727-41.
27. Sigwart U, Urban P, Golf S, et al. Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation 1988;78:1121-7.
28. de Feyter PJ, DeScheerder I, van den Brand M, et al. Emergency stenting for refractory acute coronary artery occlusion. Am J Cardiol 1990;66:1147-50.
29. Haude M, Erbel R, Straub U, et al. Results of intracoronary stents for management of coronary dissection after balloon angioplasty. Am J Cardiol 1991;67:691-6.
30. Maiello L, Colombo A, Gianrossi R, McCanny R, Finci L. Coronary stenting for treatment of acute or threatened closure following dissection after coronary balloon angioplasty. Am Heart J 1993;125:1570-5.
31. Lincoff AM, Topol EJ, Chapekis AT, et al. Intracoronary stenting compared with conventional therapy for abrupt vessel closure complicating coronary angioplasty: a matched case-control study. J Am Coll Cardiol 1993;21:866-75.
32. Metz D, Urban P, Hoang V, et al. Predicting ischemic complications after bailout stenting following failed coronary angioplasty. Am J Cardiol 1994;74:271-4.
33. Hamm CW. The Strecker stent. In Ref. 26:742-53.
34. Fischman DL, Savage MP, Leon MB, et al. Effect of intracoronary stenting on intimal dissection after balloon angioplasty results of quantitative and qualitative coronary analysis. J Am Coll Cardiol 1991;17:1445-51.
35. Block PC, Myler RK, Stenzer S, Fallon JT. Morphology after transluminal angioplasty in human beings. N Engl J Med 1981;305:382-5.
36. Bermejo J, Garcia-Robles JA, Garcia EJ, et al. Subacute occlusion after coronary stenting: predictors, management and mid-term outcome [abstract]. Circulation 1994;90 Suppl I:I-650.
37. Tamura T, Nakagawa Y, Sawada Y, et al. Comparison with three different indications of Palmaz-Schatz stent implantation [abstract]. J Invas Cardiol 1995;7:8A.
38. DeWood GW, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902.
39. Vetrotec GW, Cowley MJ, Overton H, Richardson DW. Intracoronary thrombus in syndromes of unstable myocardial ischemia. Am Heart J 1981;102:1202-8.
40. Malosky SA, Hirshfeld JWJ, Hermann HC. Comparison of results of intracoronary stenting in patients with unstable vs stable angina. Cathet Cardiovasc Diagn 1994;31:95-101.
41. Robinson NMK, Thomas MR, Wainwright RJ, Jewitt DE. Unstable angina is not a contraindication to intracoronary stent insertion. J Invas Cardiol 1995;7:6A.
42. Iyer SS, Bilodeau L, Cannon AD, et al. Stenting the infarct related artery within 15 days of the acute event: immediate and long term outcome using the flexible metallic coil stent [abstract]. J Am Coll Cardiol 1993;21:291A.
43. Marco J, Caillard J-B, Doucet S, et al. Is recent myocardial infarction a worst setting for coronary stent implantation? [abstract]. J Am Coll Cardiol 1993;21:178A.
44. Liu MW, Voorhees WD III, Agrawal S, Dean LS, Roubin GS. Stratification of the risk of thrombosis after intracoronary stenting for threatened or acute closure complicating coronary balloon angioplasty: a Cook Registry study. Am Heart J 1995;130:8-13.
45. Wong SC, Hirschfeld J, Teirstein P, et al. Differential impact of stent versus PICA on restenosis in large (5:3 mm) and small (<3 mm) vessels in the STent REStenosis Study. [abstract]. J Am Coll Cardiol 1995;25:375A.
46. Rocha-Singh K, Morris N, Wong SC, Schatz RA, Teirstein PS. Coronary stenting for treatment of ostial stenoses of native coronary arteries or aortocoronary saphenous venous grafts. Am J Cardiol 1995;75:26-9.
47. Grinstead WC, Raizner AE, Churchill DA, et al. Intracoronary thrombus prior to stenting: impact on angiographic success and clinical outcome [abstract]. J Am Coll Cardiol 1993;21:30A.
48. Bilodeau L, Iyer SS, Cannon AD, et al. Stenting as an adjunct to balloon angioplasty for recanalization of totally occluded coronary arteries: clinical and angiographic follow-up. [abstract]. J Am Coll Cardiol 1993;21:292A.
49. Almagor Y, Borrione M, Maiello L, et al. Coronary stenting after recanalization of chronic total coronary occlusion [abstract]. Circulation 1993;88 Suppl I:I-504.
50. Bailey SR, Ricci D, Kiesz S, et al. Incidence and clinical impact of dissections after PTCA and stent placement: results from the randomized STent REStenosis Study [abstract]. Circulation 1994;90 Suppl I:I-649.
51. Eeckhout E, Stauffer J-C, Vogt P, Kappenberger L, Goy J-J. Can early closure and restenosis following endoluminal stenting be predicted from clinical and angiographical variables at the time of intervention? [abstract]. J Invas Cardiol 1995;7:7A.
52. Heuser R, Cleman M, Cabin H, et al. The LAD subgroup in the Stent REStenosis Study: early and late angiographic and clinical outcomes [abstract]. Circulation 1994;90 Suppl I:I-323.
53. Plakto WP, Hollman J, Whitlow P. Percutaneous transluminal angioplasty of saphenous vein graft stenosis: long term follow-up. J Am Coll Cardiol 1989;14:1645-50.
54. Urban P, Sigwart U, Golf S, et al. Intravascular stenting for stenosis of aortocoronary venous bypass grafts. J Am Coll Cardiol 1989;13:1085-91.
55. Leon MB, Ellis SG, Pichard AD, et al. Stents may be the preferred treatment for focal aortocoronary vein graft disease [abstract]. Circulation 1991;84 Suppl II:II-249.
56. de Scheerder IK, Strauss BH, de Feyter PJ, et al. Stenting of venous bypass grafts: a new treatment modality for patients who are poor candidates for reintervention. Am Heart J 1992;123:1046-54.
57. Strumpf RK, Mehta SS, Ponder R, Heuser RR. Palmaz-Schatz stent implantation in stenosed saphenous vein grafts: clinical and angiographic follow-up. Am Heart J 1992;123:1329-36.
58. Bernardi MW, MacIsaac AI, Ellis SG, Franco IF, Whitlow PL. Is the Palmaz biliary stent the percutaneous intervention of choice for diseased aortocoronary saphenous vein grafts? [abstract]. Circulation 1993;88 Suppl I:I-661.
59. Piana RN, Moscucci M, Cohen DJ, et al. Palmaz-Schatz stenting for treatment of focal vein graft stenosis: immediate results and long-term outcome. J Am Coll Cardiol 1994;23:1296-304.
60. Fenton SH, Fischman DL, Savage MP, et al. Long-term angiographic and clinical outcome after implantation of balloon-expandable stents in aorto-coronary saphenous vein grafts. Am J Cardiol 1994;74:1187-91.
61. Dorros G, Bates MC, Iyer S, et al. The use of Gianturco-Roubin flexible metallic coronary stents in old saphenous vein grafts: in-hospital outcome and 7 day angiographic patency. Eur Heart J 1994;15:1456-62.
62. Rechavia E, Litrack F, Macko G, Eigler NI. Stent implantation of saphenous vein graft aorto-ostial lesions in patients with unstable ischemic syndromes: immediate angiographic and long-term clinical outcome. J Am Coll Cardiol 1995;25:866-70.
63. Ryan TJ, Bauman WB, Kennedy JW, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report for the American College/ American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 1993;22:2033-54.
64. Rocha-Singh KJ, Fischman DL, Savage MP, et al. Influence of angiographic lesion characteristics on early complication rates after Palmaz-Schatz stenting [abstract]. J Am Coll Cardiol 1993;21:292A.
65. Zollikofer CL, Largiader I, Bruhlmann WF, Uhlschmid GK, Marty AH. Endovascular stenting of veins and grafts: preliminary clinical experience. Radiology 1988;167:707-12.
66. MacIsaac AI, Ellis SG, Muller DW, Topol EJ, Whitlow PL. Comparison of three coronary stents: clinical and angiographic outcome after elective placement in 134 patients. Cathet Cardiovasc Diagn 1994;33:199-204.
67. Kimura T, Nosaka H, Yoka N, et al. Initial experience with the Strecker coronary stent [abstract]. J Am Coll Cardiol 1992;19:198A.
68. Sheth S, Dev V, Fishbein MC, et al. Reduced thrombogenicity of nitinol vs. stainless steel slotted stents in rabbit carotid arteries [abstract]. J Am Coll Cardiol 1995;25:240A.
69. Bailey SR. Coating of endovascular stents. In: Topol EJ, ed. Textbook of Interventional Cardiology. Philadelphia: W. B. Saunders, 1994:754-65.
70. Bailey SR, Paige S, Lunn A, Palmaz J. Heparin coating of endovascular stents decreases subacute thrombosis in a rabbit model [abstract]. Circulation 1992;86 Suppl I:I-186.
71. van der Giessen WJ, Hardhammar PA, van Beusekon MM, et al. Prevention of (sub)acute thrombosis using heparin-coated stents [abstract]. Circulation 1994;90 Suppl I:I-650.
72. Emmauelsson H, Serruys PW, Belardi J, et al. Clinical experience with heparin-coated stents - the Benestent II pilot phase I [abstract]. J Am Coll Cardiol 1995;25:181A.
73. Serruys PW, Di Mario C. Who was thrombogenic: the stent or the doctor? Circulation 1995;91:1891-3.
74. Goldberg SL, Colombo A, Nakamura S, et al. Benefit of intracoronary ultrasound in the deployment of Palmaz-Schatz stents. J Am Coll Cardiol 1994;24:996-1003.
75. Caputo RP, Lopez JJ, Ho KKL, et al. Intravascular ultrasound analysis of routine high pressure post-dilatation after Palmaz-Schatz deployment [abstract]. J Am Coll Cardiol 1995;25:49A.
76. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-88.
77. Jain SP, Liu MW, Iyer SS, et al. Do high pressure balloon inflation improve acute gain within metallic coil stents? [abstract]. J Am Coll Cardiol 1995;25:49A.
78. Mudra H, Klauss V, Blasini R, et al. Ultrasound guidance of Palmaz-Schatz intracoronary stenting with a combined intravascular ultrasound balloon catheter. Circulation 1994;90:1252-61.
79. Jeong MH, Owen WG, Srivatsa SS, et al. Platelets are the primary component of acute stent thrombosis [abstract]. J Invas Cardiol 1995;7:11A.
80. Elias J, Monasser JP, Puel J, et al. Medtronic Wiktor stent implantation without coumadin: hospital outcome [abstract]. Circulation 1994;90 Suppl 1:1-124.
81. Aubry P, Royer T, Spaulding C, et al. Coronary stenting without coumadin: phase II and III. The bail-out group [abstract]. Circulation 1994;90 Suppl I:I-124.
82. Blengino S, Maiello L, Hall P, et al. Randomized trial of coronary stent implantation without anticoagulation: aspirin vs. ticlodipine [abstract]. Circulation 1994;90 Suppl I:I-124.
83. Morice M-C, Bourdonnec C, Lefevre T, et al. Coronary stenting without coumadin. Phase III. [abstract]. Circulation 1994;90 Suppl I:I-125.
84. Carvalho H, Fajadet J, Jordan C, et al. A lower rate of complications after Gianturco-Roubin coronary stenting using a new antiplatelet and anticoagulant protocol [abstract]. Circulation 1994;90 Suppl I:I-125.
85. Jordan C, Carvalho H, Fajadet J, et al. Reduction of subacute thrombosis after coronary stenting using a new anticoagulant protocol [abstract]. Circulation 1994;90 Suppl I:I-125.
86. Barragan P, Sainsous J, Silvestri M, et al. Ticlodipine and subcutaneous heparin as an alternative regimen following coronary stenting. Cathet Cardiovasc Diagn 1994;32:133-8.
87. Blasini R, Mudra H, Schühlen H, et al. Intravascular ultrasound guided optimized emergency coronary Palmaz-Schatz stent placement without post-procedural systemic anticoagulation [abstract]. J Am Coll Cardiol 1995;25:197A.
88. Colombo A, Nakamura S, Hall P, et al. A prospective study of Gianturco-Roubin coronary stent implantation without anticoagulation [abstract]. J Am Coll Cardiol 1995;25:50A.
89. Russo RJ, Schatz RA, Sklar MA, et al. Ultrasound guided coronary stent placement without prolonged systemic anticoagulation [abstract]. J Am Coll Cardiol 1995;25:50A.
90. Wong SC, Popma JJ, Chuang YC, et al. Economic impact of reduced anticoagulation after saphenous vein graft stent placement [abstract]. J Am Coll Cardiol 1995;25:181A.
91. Lablanchè J-M, Grollier G, Danchin N, et al. Full antiplatelet therapy without anticoagulation after coronary stenting [abstract]. J Am Coll Cardiol 1995;25:181A.
92. Barragan P, Silvestri M, Sainsous J, et al. Prevention of subacute occlusion after coronary stenting with ticlodipine regimen without intravascular ultrasound guided stenting [abstract]. J Am Coll Cardiol 1995;25:182A.
93. Fajadet J, Jordan C, Carvalho H, et al. Percutaneous trans radial coronary stenting without coumadin can reduce vascular access complications and hospital stay [abstract]. J Am Coll Cardiol 1995;25:182A.
94. van Belle E, McFadden EP, Bauters C, et al. Combined antiplatelet therapy without anticoagulation: an effective alternative to prevent subacute thrombosis after coronary stenting? A 3 month follow-up [abstract]. J Am Coll Cardiol 1995;25:197A.
95. Schühlen H, Blasini R, Mudra H, et al. Stenting for progressive dissection during PTCA: clinical, angiographic and intravascular ultrasound criteria to define low-risk group not requiring subsequent anticoagulation [abstract]. J Am Coll Cardiol 1995;25:239A.
96. Colombo A, Nakamura S, Hall P, et al. A prospective study of Wiktor coronary stent implantation without anticoagulation [abstract]. J Am Coll Cardiol 1995;25:239A.
97. Corcos T, Garcia-Cantu E, Guerin Y, et al. Coronary stenting without anticoagulation. Results in 100 consecutive patients [abstract]. J Invas Cardiol 1995;7:5A.
98. Tresukosol D, Schalij MJ, Jukema W, Buis B, Reiber JHC. The Micro Stent. Quantitative angiographic analysis and procedural results [abstract]. J Invas Cardiol 1995;7:8A.
99. Savalle LH, Schalij MJ, Tresukosol D, et al. A prospective study of intracoronary stenting without subsequent anticoagulation. Initial results [abstract]. J Invas Cardiol 1995;7:8A.
100. Mattos L, Chaves A, Feres F, et al. Optimal coronary stent implantation without ultrasound guidance withholding subsequent anticoagulation. Can it be done safely? [abstract]. J Invas Cardiol 1995;7:10A.
101. Lefèvre T, Bernard A, Chopat P, Couturier P, Lier D. Coronary stenting with coumadin or ticlodipine? [abstract]. J Invas Cardiol 1995;7:11A.
102. Drug Information for the Health Care Professional. Ticlodipine. Rockville, MD: United States Pharmacopoieal Convention, 1995:2691-4.